Q4 2023 13F Holders as of 12/31/2023
-
Type / Class
-
Equity / Common Stock, par value $0.00001 per share
-
Shares outstanding
-
38.5M
-
Number of holders
-
38
-
Total 13F shares, excl. options
-
24.1M
-
Shares change
-
+78.7K
-
Total reported value, excl. options
-
$27M
-
Value change
-
+$88.3K
-
Number of buys
-
15
-
Number of sells
-
-12
-
Price
-
$1.12
Significant Holders of Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) as of Q4 2023
39 filings reported holding BOLT - Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share as of Q4 2023.
Bolt Biotherapeutics, Inc. - Common Stock, par value $0.00001 per share (BOLT) has 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 24.1M shares
of 38.5M outstanding shares and own 62.64% of the company stock.
Largest 10 shareholders include TANG CAPITAL MANAGEMENT LLC (3.65M shares), Vivo Capital, LLC (3.52M shares), Sofinnova Investments, Inc. (2.75M shares), CITADEL ADVISORS LLC (2.46M shares), Pivotal bioVenture Partners Investment Advisor LLC (1.89M shares), Newtyn Management, LLC (1.55M shares), ORBIMED ADVISORS LLC (1.54M shares), Nan Fung Group Holdings Ltd (1.17M shares), Samsara BioCapital, LLC (1.05M shares), and VANGUARD GROUP INC (931K shares).
This table shows the top 38 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.